SCHEMBL13506831

SCHEMBL13506831

Cc1ccc(N(c2ccc(C)cc2)c2ccc3c4c5ccc6c(c5ccc4n(C)c3c2)c2ccc(N(c3ccc(C)cc3)c3ccc(C)cc3)cc2n6C)cc1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ THRB P10828 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ GLA P06280 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ BCHE P06276 2/20 0.33
▸ ACHE P22303 2/20 0.33
▸ NQO2 P16083 1/20 0.32
▸ TSHR P16473 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.30
▸ TOP2A P11388 1/20 0.30
▸ POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507568 0.94 BCHE (0.38) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL13506824 0.87 NQO2 (0.38) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL14073442 0.85 ALDH1A1 (0.37) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL13507016 0.84 BCHE (0.32) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL13508148 0.83 KDM4E (0.41) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL13507094 0.83 KIF11 (0.35) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL13507575 0.82 MAOB (0.38) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL13241956 0.81 BCHE (0.40) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL13507560 0.81 TP53 (0.39) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL14646290 0.81 GPR3 (0.52) ALDH1A1MAPTKDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 ALDH1A1 119/4885MAPT 2046/4885KDM4E 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback